ZA919682B - Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax - Google Patents

Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax

Info

Publication number
ZA919682B
ZA919682B ZA919682A ZA919682A ZA919682B ZA 919682 B ZA919682 B ZA 919682B ZA 919682 A ZA919682 A ZA 919682A ZA 919682 A ZA919682 A ZA 919682A ZA 919682 B ZA919682 B ZA 919682B
Authority
ZA
South Africa
Prior art keywords
pneumothorax
polypeptide
activity
preparation
treatment
Prior art date
Application number
ZA919682A
Inventor
Maud Brandely
Brandely Maud
Christian Boutin
Boutin Christian
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA919682B publication Critical patent/ZA919682B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The subject of the invention is the use of a polypeptide having human interleukin-2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax.
ZA919682A 1991-01-17 1991-12-09 Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax ZA919682B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100488A FR2671728B1 (en) 1991-01-17 1991-01-17 USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PNEUMATHORAX.

Publications (1)

Publication Number Publication Date
ZA919682B true ZA919682B (en) 1993-02-24

Family

ID=9408769

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919682A ZA919682B (en) 1991-01-17 1991-12-09 Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax

Country Status (12)

Country Link
EP (1) EP0495721B1 (en)
JP (1) JP3481954B2 (en)
KR (1) KR100216005B1 (en)
AT (1) ATE124264T1 (en)
AU (1) AU645653B2 (en)
CA (1) CA2059512A1 (en)
DE (1) DE69203098T2 (en)
DK (1) DK0495721T3 (en)
FR (1) FR2671728B1 (en)
HU (1) HU207228B (en)
OA (1) OA09530A (en)
ZA (1) ZA919682B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08177807A (en) * 1994-12-26 1996-07-12 Smc Corp Rodless cylinder having position sensor and brake

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635527B1 (en) * 1988-07-28 1992-06-12 Roussel Uclaf NON-GLYCOSYLATED RECOMBINANT HUMAN IL2 IN REDUCED FORM, PROCESS FOR OBTAINING IT, AND APPLICATION THEREOF AS A MEDICAMENT
FR2653020B1 (en) * 1989-10-17 1993-03-26 Roussel Uclaf USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEUKEMIA.
FR2660863B1 (en) * 1990-04-17 1994-01-21 Roussel Uclaf USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PRIMITIVE CANCERS OF THE POWDER.

Also Published As

Publication number Publication date
KR100216005B1 (en) 1999-08-16
KR920014480A (en) 1992-08-25
JPH0558907A (en) 1993-03-09
JP3481954B2 (en) 2003-12-22
EP0495721B1 (en) 1995-06-28
OA09530A (en) 1992-11-15
CA2059512A1 (en) 1992-07-18
FR2671728B1 (en) 1995-01-20
HU9200147D0 (en) 1992-04-28
ATE124264T1 (en) 1995-07-15
DK0495721T3 (en) 1995-10-30
AU645653B2 (en) 1994-01-20
EP0495721A1 (en) 1992-07-22
HUT60145A (en) 1992-08-28
HU207228B (en) 1993-03-29
AU1022192A (en) 1992-07-23
FR2671728A1 (en) 1992-07-24
DE69203098D1 (en) 1995-08-03
DE69203098T2 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
AU6190194A (en) Pharmaceutical containing the P40 subunit of interleukin 12
CA2123315A1 (en) Therapeutic agents which are antagonists or partial agonists of human interleukin 4
AU6466790A (en) Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
EP0271211A3 (en) Use of cartilage-inducing factor b (cif-b) for the manufacture of a medicament for inhibiting tumor growth
HUT58204A (en) Magnesium-pyridoxale-5'-phosphate-glutaminate for preventing diseases originated from blood-vessel-alternations
IL89662A0 (en) Pharmaceutical compositions comprising interferon-beta 1
DK0452598T3 (en) The use of a polypeptide with human interleukin-2 activity in the preparation of pharmaceutical compositions for the treatment of primitive pleural cancer
ZA919682B (en) Use of a polypeptide having human interleukin 2 activity for the preparation of pharmaceutical compositions for the treatment of pneumothorax
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
IL104132A0 (en) Compositions for the treatment of mammalian diseases
EP0732401A3 (en) Megakaryocyte stimulating factor (meg-CSF)
AU7052191A (en) Antitumoral composition based on polypeptides having human interleukin 2 activity
EP0968721A3 (en) Use of a composition comprising a peptide for the inhibition of HIV
EP0312132A3 (en) Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine
AU645042B2 (en) Use of a polypeptide having the activity of gamma interferon for the preparation of pharmaceutical compositions intended for the treatment of primary cancers of the pleura
GR920300126T1 (en)
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
IL91427A0 (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
GR3006713T3 (en)
GB9104920D0 (en) Therapeutical composition for the treatment of multiple sclerosis
ZA906355B (en) Pharmaceutical compositions for the treatment of multiple sclerosis
ZA935120B (en) Medicinal compositions for the improvement of blood coagulation comprising TCF-II
IT1263244B (en) USE OF ZINC CHLORIDE FOR THE PRODUCTION OF A PREPARATION FOR THE THERAPY AND THE PROPHYLAXIS OF STOMATOLOGICAL INJURIES.